News
Data concerns mount despite ISCHEMIA substudy correction
A second correction is forthcoming, and cardiac surgeons are calling for full disclosure of the trial’s coronary artery disease severity data for...
News
Distal radial snuffbox technique comes up short in DISCO RADIAL
The trial missed its primary endpoint but bolsters the case for using the technique when coupled with best practices to prevent radial artery...
News
ISCHEMIA substudy data don’t add up, cardiac surgeons say
Discrepancies between the paper and supplemental data have been slow to come to light, but the substudy authors say it’s a simple formatting error...
News
FDA approves Medtronic’s Onyx Frontier drug-eluting stent
The low-profile stent shares the same platform as the previous-generation Resolute Onyx zotarolimus-eluting stent and features an enhanced...
News
Antithrombotic therapies shifting for Watchman LAA occlusion
National registry data show substantial deviation from the treatment protocols used in the pivotal randomized trials in the years following...
News
Topline results for dapagliflozin in HFpEF: DELIVER
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.
News
‘Embarrassing’: High-intensity statin uptake in ASCVD patients ‘terrible’
A national study uncovered abysmal rates of usage for one of the most studied and inexpensive therapies available.
News
First-ever best practices for percutaneous axillary access
A new position statement from the Society for Cardiovascular Angiography and Interventions suggests best practices for this increasingly...
News
Study points to causal role for Lp(a) in atrial fibrillation
The relation is relatively modest but strongly argues for increased testing of Lp(a) and adding atrial fibrillation as a secondary outcome to...
News
Renal denervation BP benefits remain at 3 years: SPYRAL HTN-ON
Results from the sham-controlled trial suggest renal denervation may provide an alternative “adjunctive treatment” in the management of...
News
APOLLO: SLN360 clears first major hurdle, hammering Lp(a)
The results add to growing enthusiasm for achieving the ‘holy grail’ of a lipoprotein(a)-specific lowering agent, but whether it will reduce...
News
POISE-3 backs wider use of tranexamic acid in noncardiac surgery
The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role...
News
Even moderate exercise offers strong shield from COVID-19
“Should we come across further waves of this pandemic, our advice from a medical point of view should be to promote and facilitate exercise.”
News
Surgery groups push back on VARC-3 valve trial definitions
A new position statement says the updated VARC-3 document on clinical endpoint definitions provides many important contributions, but “some...
News
Sit-to-stand BP spike tied to CV events in young adults
Orthostatic hypertension blood pressure assessment provides prognostic information on top of traditional risk factors and ambulatory blood...